Amy Lynn Kessler

Amy Lynn Kessler

Auto-generated profile, based on publicly available information

Amy Lynn Kessler

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
DMDario F. Marzella
Dario F. Marzella
GCGiulia Crocioni
Giulia Crocioni
TRTadija Radusinović
Tadija Radusinović
DLDaniil Lepikhov
Daniil Lepikhov
HSHeleen Severin
Heleen Severin
LXLi C. Xue
Li C. Xue
The interaction between peptides and major histocompatibility complex (MHC) molecules is pivotal in autoimmunity, pathogen recognition and tumor immunity. Recent advances in cancer immunotherapies demand for more accurate computational prediction of MHC-bound peptides. We address the generalizability challenge of MHC-bound peptide predictions, revealing limitations in current sequence-based approaches. Our structure-based methods leveraging geometric deep learning (GDL) demonstrate promising improvement in generalizability across unseen MHC alleles. Further, we tackle data efficiency by introducing a self-supervised learning approach on structures (3D-SSL). Without being exposed to any binding affinity data, our 3D-SSL outperforms sequence-based methods trained on ~90 times more data points. Finally, we demonstrate the resilience of structure-based GDL methods to biases in binding data on an Hepatitis B virus vaccine immunopeptidomics case study. This proof-of-concept study highlights structure-based methods’ potential to enhance generalizability and data efficiency, with possible implications for data-intensive fields like T-cell receptor specificity predictions.

12 August 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
AKAmy L. Kessler
Amy L. Kessler
KFKyle L. Fort
Kyle L. Fort
HRHanno C. Resemann
Hanno C. Resemann
PKPeter Krüger
Peter Krüger
CWCong Wang
Cong Wang
AHAlbert Heck
Albert Heck
Gaining a complete and unbiased understanding of the non-tryptic peptide repertoire presented by HLA-I complexes by LC-MS/MS is indispensable for therapy design for cancer, autoimmunity and infectious diseases. A serious concern in HLA peptide analysis is that the routinely used, collision-based fragmentation methods (CID/HCD) do not always render sufficiently informative MS2 spectra, whereby gaps in the fragmentation sequence coverage prevent unambiguous assignments. EThcD can be utilized to generate complementary ion series, i.e. b/y ions and c/z ions, resulting in richer, more informative MS2 spectra, thereby filling in the gaps. Here, we present data generated on a novel hybrid Orbitrap mass spectrometer, facilitating fast and efficient hybrid fragmentation due to the implementation of EThcD in the ion routing multipole. We hypothesized that this would enable more comprehensive and less error-prone analysis of immunopeptidomes at minimal costs in duty-cycle. First, we optimized ETD/EThcD methods using an elastase-digested cell lysate, as this contains peptides of similar length and charge distributions to immunopeptides. Next, we compared HCD and EThcD on immunopeptidomes originating from three cell lines with distinct HLA-I complexes that present peptides with varying physicochemical properties. We demonstrate that the new instrument not only enables efficient and fast ETD reactions, but when combined with collision-based supplemental activation, i.e. EThcD, also consistently increases the sequence coverage and identification of peptide sequences, otherwise missed by using solely HCD. We reveal several of the biochemical properties that make HLA peptides preferably identifiable by EThcD, with internal Arg residues being one of the most dominant determinants. Finally, we demonstrate the power of EThcD for the identification and localization of HLA peptides harboring post-translational modifications, focusing here on HLA Arg mono-/di-methylation. We foresee that this new instrument with efficient EThcD capabilities enhances not only immunopeptidomics analysis, but also analysis of peptides harboring post-translational modifications and de novo sequencing.

5 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDario F. Marzella
Dario F. Marzella
GCGiulia Crocioni
Giulia Crocioni
TRTadija Radusinovic
Tadija Radusinovic
DLDaniil Lepikhov
Daniil Lepikhov
HSHeleen Severin
Heleen Severin
LXLi C. Xue
Li C. Xue
Understanding the peptide presentation mechanism of Major Histocompatibility Complex (MHC) is crucial to study the recognition of pathogens, the treatment of autoimmune diseases and in developing cancer immunotherapies. To comprehend these mechanisms and design effective therapies at affordable costs, it is fundamental to be able to precisely predict in silico which peptides can be bound by each MHC. Many computational approaches have been developed to identify MHC-binding peptides based on their sequences, however, they present biases and their performance on less-studied MHC alleles with limited experimental binding data is severely restricted by their sequence-based (SeqB) nature. We reason that structure-based (StrB) methods could learn the physico-chemical and geometrical rules of peptide-MHC (pMHC) complexes conserved among the alleles, thus generalizing better. We designed three supervised StrB geometric deep learning (GDL) methods, showing superior generalization across all StrB methods over two SeqB methods when the test data is distant from the training data. To further explore data efficiency, we designed a novel self-supervised GDL approach trained only on ∼1K x-ray structures, 3D-SSL, which predicts binding affinities without seeing any during training. Finally, we showcase our StrB method on a case study from the HPV vaccine design to show how StrB methods are robust to biases in the binding data. These findings highlight the potentials of structure-based methods in efficiently utilizing limited data, enhancing generalizability. This study bears important implications on data hungry fields, for example, the long-standing T cell receptor (TCR) specificity challenge.

1 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAmy L. Kessler
Amy L. Kessler
KFKyle L. Fort
Kyle L. Fort
HRHanno C. Resemann
Hanno C. Resemann
PKPeter Krueger
Peter Krueger
CWCong Wang
Cong Wang
AHAlbert Heck
Albert Heck
Gaining a complete and unbiased understanding of the non-tryptic peptide repertoire presented by HLA-I complexes by LC-MS/MS is indispensable for therapy design for cancer, autoimmunity and infectious diseases. A serious concern in HLA peptide analysis is that the routinely used, collision-based fragmentation methods (CID/HCD) do not always render sufficiently informative MS2 spectra, whereby gaps in the fragmentation sequence coverage prevent unambiguous assignments. EThcD can be utilized to generate complementary ion series, i.e. b/y ions and c/z ions, resulting in richer, more informative MS2 spectra, thereby filling in the gaps. Here, we present data generated on a novel hybrid Orbitrap mass spectrometer, facilitating fast and efficient hybrid fragmentation due to the implementation of EThcD in the ion routing multipole. We hypothesized that this would enable more comprehensive and less error-prone analysis of immunopeptidomes at minimal costs in duty-cycle. First, we optimized ETD/EThcD methods using an elastase-digested cell lysate, as this contains peptides of similar length and charge distributions to immunopeptides. Next, we compared HCD and EThcD on immunopeptidomes originating from three cell lines with distinct HLA-I complexes that present peptides with varying physicochemical properties. We demonstrate that the new instrument not only enables efficient and fast ETD reactions, but when combined with collision-based supplemental activation, i.e. EThcD, also consistently increases the sequence coverage and identification of peptide sequences, otherwise missed by using solely HCD. We reveal several of the biochemical properties that make HLA peptides preferably identifiable by EThcD, with internal Arg residues being one of the most dominant determinants. Finally, we demonstrate the power of EThcD for the identification and localization of HLA peptides harboring post-translational modifications, focusing here on HLA Arg mono-/di-methylation. We foresee that this new instrument with efficient EThcD capabilities enhances not only immunopeptidomics analysis, but also analysis of peptides harboring post-translational modifications and de novo sequencing.

5 July 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
DMDario F. Marzella
Dario F. Marzella
GCGiulia Crocioni
Giulia Crocioni
TRTadija Radusinović
Tadija Radusinović
DLDaniil Lepikhov
Daniil Lepikhov
HSHeleen Severin
Heleen Severin
LXLi C. Xue
Li C. Xue

15 January 2022 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
RBRachid Bouzid
Rachid Bouzid
AKAmy L. Kessler
Amy L. Kessler
ILiris levink
iris levink
TBThierry P.P. van Den Bosch
Thierry P.P. van Den Bosch
SBSonja Buschow
Sonja Buschow
MDMichail Doukas
Michail Doukas